Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The World Bank has significantly downgraded its economic growth projections for Romania this year, lowering expectations to 0.5% from the 1.3% forecast issued at the start of 2026.
Foraj Sonde Videle has announced the acquisition of Raffles Energy, a British holding company that owns two Romanian energy companies active in natural gas and electricity production.
Econergy Renewable Energy has secured approximately €31 million in project financing from Kommunalkredit Austria to develop its 60 MW photovoltaic project in southeastern Romania.
Romanian software company Arobs Transilvania Software has completed the merger by absorption of five subsidiaries - Arobs Development & Engineering, Berg Computers, Nordlogic Software, Infobest Romania, and Centrul de Soft GPS.
The European retail sector faced a cooling period in February 2026, with the latest Eurostat data revealing a divergence between a stabilising Union and a sharply declining Romanian market.